No insider purchase over the last 90 days. The latest was filed 04 Aug 2025.
This page follows insider dealings at Abpro Holdings, Inc. as filed with SEC (Form 4). Abpro Holdings, Inc. has had no insider filing for more than a year; the last one goes back to 4 August 2025.
Our records for Abpro Holdings, Inc. go back to 2023, with 4 purchases and no sales on the open market in total.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
15 of 15 declarations
Abpro Holdings, Inc. is a NASDAQ-listed company specializing in the development of antibody-based therapies. It focuses on innovative solutions for treating various diseases.
Purchases our model currently ranks for the recommendations list.
All recommendations